Cargando…

Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries

BACKGROUND: The Xpert(®) MTB/RIF (Xpert) is an automated molecular test for simultaneous detection of tuberculosis (TB) and rifampicin resistance, recommended by the World Health Organization as the preferred diagnostic method for individuals presumed to have multi-drug resistant TB (MDR-TB) or HIV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ardizzoni, Elisa, Fajardo, Emmanuel, Saranchuk, Peter, Casenghi, Martina, Page, Anne-Laure, Varaine, Francis, Kosack, Cara S., Hepple, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682866/ https://www.ncbi.nlm.nih.gov/pubmed/26670929 http://dx.doi.org/10.1371/journal.pone.0144656

Ejemplares similares

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
por: Cayci, Yeliz Tanriverdi, et al.
Publicado: (2017)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2022)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
por: Zong, Kaican, et al.
Publicado: (2019)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
por: Wu, Zheyuan, et al.
Publicado: (2020)

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
por: Shapiro, Adrienne E, et al.
Publicado: (2021)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
por: Diriba, Kuma, et al.
Publicado: (2021)

Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
por: Feliciano, Cinara Silva, et al.
Publicado: (2019)

Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
por: Khaparde, Sunil, et al.
Publicado: (2017)

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF
por: Seifert, Marva, et al.
Publicado: (2021)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
por: Mukhida, Sahjid, et al.
Publicado: (2022)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients
por: Schutz, Charlotte, et al.
Publicado: (2019)

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
por: De Vos, Elise, et al.
Publicado: (2023)

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
por: Dorman, Susan E, et al.
Publicado: (2018)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2015)

The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China
por: Lu, Jie, et al.
Publicado: (2017)

Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study
por: Soeroto, Arto Yuwono, et al.
Publicado: (2019)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
por: Atashi, S., et al.
Publicado: (2017)

Detection of Mycobacterium tuberculosis and Rifampicin Resistance Using GeneXpert MTB/RIF Assay at Enat Hospital, Central Ethiopia
por: Selfegna, Sebsib, et al.
Publicado: (2022)

Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis
por: Patel, Sakshi, et al.
Publicado: (2023)

Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation
por: Ghebrekristos, Yonas T, et al.
Publicado: (2023)

Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis
por: Yu, Wenfeng, et al.
Publicado: (2022)

Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study
por: Wasihun, Araya Gebreyesus, et al.
Publicado: (2020)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
por: Boulware, David R.
Publicado: (2013)

Prevalence of Tuberculous Spondylodisciitis and Diagnostic Utility of Xpert MTB RIF
por: Ananthanarayanan, Rajalakshmi, et al.
Publicado: (2017)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eio3e7m3ctaet2d5b0c1kadk3v